Patent ID: 6964973

Claim:
A compound having the formula: wherein: R 3 and R 4 are each independently selected from the group of hydrogen, C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 1 -C 8 haloalkyl, C 1 -C 8 heteroalkyl, heteroaryl, and aryl, wherein the alkyl, alkenyl, alkynyl, haloalkyl, heteroalkyl, heteroaryl, and aryl are optionally substituted with halogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 heteroalkyl; R 3A is aryl or heteroaryl, wherein the aryl and heteroaryl is optionally substituted with halogen, CN, NO 2 , C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 heteroalkyl; R 5 is selected from the group of hydrogen, F, Cl, Br, I, OR 3 , SR 3 , NR 3 R 4 , C 1 -C 4 alkyl, C 1 -C 4 haloalkyl or C 1 -C 4 heteroalkyl; R 7 and R 8 are each independently selected from the group of hydrogen, F, Cl, Br, I, CN, OR 3 , NR 3 R 4 , NR 3 CR 3 R 4 CONR 3 R 4 , C n (R 3 ) 2n OR 3 , SR 3 , SOR 3 , SO 2 R 3 , NR 3 COR 4 , C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, and C 1 -C 8 heteroalkyl; R 9 is selected from the group of hydrogen, F, Br, Cl, I, OR 3 , NR 3 R 4 , SR 3 , SOR 3 , SO 2 R 3 , C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and C 1 -C 4 heteroalkyl; R 11 is selected from the group of F, Br, Cl, I, C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 1 -C 6 heteroalkyl, NO 2 , CN, CF 3 , OR 3 , NR 3 R 4 , SR 3 , SOR 3 , and SO 2 R 3 ; R 12 is selected from the group of F, Br, Cl, I, CN, OR 3 , SR 3 , SOR 3 , SO 2 R 3 , NR 3 R 4 , and C 1 -C 4 haloalkyl; R 16 is selected from the group of hydrogen, C 1 -C 8 alkyl, C 1 -C 8 haloalkyl, C 1 -C 8 heteroalkyl, CH 2 R 3A , aryl, heteroaryl, COR 17 , CO 2 R 17 , and CONR 17 R 17 ; R 17 is selected from the group of hydrogen, C 1 -C 4 alkyl, C 1 -C 4 haloalkyl and C 1 -C 4 heteroalkyl; X is NR 16 ; Y is selected from the group of O, S, NR 3 , NOR 3 and CR 3 R 4 ; n is 1, 2 or 3; and m is 1 to 5, or a pharmaceutically acceptable salt thereof.